nodes	percent_of_prediction	percent_of_DWPC	metapath
Ondansetron—CYP2C9—brain cancer	0.496	1	CbGaD
Ondansetron—CYP2D6—Lomustine—brain cancer	0.0516	0.183	CbGbCtD
Ondansetron—CYP1A2—Carmustine—brain cancer	0.0511	0.181	CbGbCtD
Ondansetron—CYP2D6—Hydroxyurea—brain cancer	0.0391	0.138	CbGbCtD
Ondansetron—CYP3A4—Temozolomide—brain cancer	0.0386	0.136	CbGbCtD
Ondansetron—CYP3A4—Lomustine—brain cancer	0.0328	0.116	CbGbCtD
Ondansetron—CYP2E1—Etoposide—brain cancer	0.0262	0.0926	CbGbCtD
Ondansetron—CYP3A5—Etoposide—brain cancer	0.0203	0.0719	CbGbCtD
Ondansetron—CYP1A2—Etoposide—brain cancer	0.0151	0.0535	CbGbCtD
Ondansetron—HTR3A—fourth ventricle—brain cancer	0.011	0.122	CbGeAlD
Ondansetron—HTR1B—dura mater—brain cancer	0.0108	0.119	CbGeAlD
Ondansetron—Injection site burning—Carmustine—brain cancer	0.00797	0.0812	CcSEcCtD
Ondansetron—CYP3A4—Etoposide—brain cancer	0.00793	0.028	CbGbCtD
Ondansetron—Alosetron—CYP2C9—brain cancer	0.00557	1	CrCbGaD
Ondansetron—Wound—Carmustine—brain cancer	0.00518	0.0528	CcSEcCtD
Ondansetron—HTR1B—trigeminal nerve—brain cancer	0.00463	0.0513	CbGeAlD
Ondansetron—HTR3A—cranial nerve—brain cancer	0.00393	0.0436	CbGeAlD
Ondansetron—Blindness—Lomustine—brain cancer	0.00342	0.0348	CcSEcCtD
Ondansetron—HTR1B—cranial nerve—brain cancer	0.0033	0.0365	CbGeAlD
Ondansetron—OPRM1—telencephalic ventricle—brain cancer	0.00293	0.0325	CbGeAlD
Ondansetron—HTR4—telencephalon—brain cancer	0.00284	0.0315	CbGeAlD
Ondansetron—Tonic-clonic seizures—Carmustine—brain cancer	0.00279	0.0284	CcSEcCtD
Ondansetron—HTR1B—telencephalic ventricle—brain cancer	0.00268	0.0297	CbGeAlD
Ondansetron—HTR4—pituitary gland—brain cancer	0.00232	0.0256	CbGeAlD
Ondansetron—HTR1A—telencephalic ventricle—brain cancer	0.00217	0.024	CbGeAlD
Ondansetron—HTR3A—ganglion—brain cancer	0.00199	0.022	CbGeAlD
Ondansetron—OPRM1—ganglion—brain cancer	0.00183	0.0202	CbGeAlD
Ondansetron—HTR1B—ganglion—brain cancer	0.00167	0.0185	CbGeAlD
Ondansetron—Grand mal convulsion—Carmustine—brain cancer	0.00158	0.0161	CcSEcCtD
Ondansetron—SLC47A1—hindbrain—brain cancer	0.00148	0.0164	CbGeAlD
Ondansetron—Visual disturbance—Lomustine—brain cancer	0.00145	0.0148	CcSEcCtD
Ondansetron—Neoplasm malignant—Procarbazine—brain cancer	0.00141	0.0143	CcSEcCtD
Ondansetron—HTR1A—ganglion—brain cancer	0.00135	0.0149	CbGeAlD
Ondansetron—SLC47A2—head—brain cancer	0.00134	0.0149	CbGeAlD
Ondansetron—HTR1B—blood vessel—brain cancer	0.00133	0.0147	CbGeAlD
Ondansetron—HTR4—brain—brain cancer	0.00128	0.0142	CbGeAlD
Ondansetron—SLC47A2—central nervous system—brain cancer	0.00123	0.0136	CbGeAlD
Ondansetron—Anorectal discomfort—Etoposide—brain cancer	0.00106	0.0108	CcSEcCtD
Ondansetron—HTR1A—hindbrain—brain cancer	0.00102	0.0113	CbGeAlD
Ondansetron—SLC47A2—brain—brain cancer	0.000973	0.0108	CbGeAlD
Ondansetron—Haemoglobin—Lomustine—brain cancer	0.000955	0.00973	CcSEcCtD
Ondansetron—Haemorrhage—Lomustine—brain cancer	0.00095	0.00968	CcSEcCtD
Ondansetron—Injection site pain—Carmustine—brain cancer	0.00092	0.00938	CcSEcCtD
Ondansetron—Visual impairment—Lomustine—brain cancer	0.000915	0.00933	CcSEcCtD
Ondansetron—HTR3A—brainstem—brain cancer	0.000865	0.00958	CbGeAlD
Ondansetron—SLC47A1—brainstem—brain cancer	0.00085	0.00941	CbGeAlD
Ondansetron—OPRM1—brainstem—brain cancer	0.000794	0.00879	CbGeAlD
Ondansetron—Toxic epidermal necrolysis—Procarbazine—brain cancer	0.000785	0.008	CcSEcCtD
Ondansetron—Laryngospasm—Etoposide—brain cancer	0.000778	0.00793	CcSEcCtD
Ondansetron—HTR3A—telencephalon—brain cancer	0.000768	0.00851	CbGeAlD
Ondansetron—Hepatic failure—Hydroxyurea—brain cancer	0.000751	0.00765	CcSEcCtD
Ondansetron—Injection site reaction—Carmustine—brain cancer	0.000747	0.00761	CcSEcCtD
Ondansetron—Musculoskeletal pain—Temozolomide—brain cancer	0.000735	0.00749	CcSEcCtD
Ondansetron—Angina pectoris—Procarbazine—brain cancer	0.000734	0.00748	CcSEcCtD
Ondansetron—HTR1B—brainstem—brain cancer	0.000726	0.00804	CbGeAlD
Ondansetron—OPRM1—telencephalon—brain cancer	0.000704	0.0078	CbGeAlD
Ondansetron—CYP3A7—endocrine gland—brain cancer	0.000685	0.00759	CbGeAlD
Ondansetron—Drowsiness—Procarbazine—brain cancer	0.000672	0.00684	CcSEcCtD
Ondansetron—Cardiovascular disorder—Etoposide—brain cancer	0.000661	0.00674	CcSEcCtD
Ondansetron—Pain—Carboplatin—brain cancer	0.00066	0.00672	CcSEcCtD
Ondansetron—HTR1B—telencephalon—brain cancer	0.000644	0.00714	CbGeAlD
Ondansetron—SLC47A1—gonad—brain cancer	0.00063	0.00697	CbGeAlD
Ondansetron—Swelling—Carmustine—brain cancer	0.000618	0.0063	CcSEcCtD
Ondansetron—SLC47A1—pituitary gland—brain cancer	0.000614	0.0068	CbGeAlD
Ondansetron—Body temperature increased—Carboplatin—brain cancer	0.00061	0.00621	CcSEcCtD
Ondansetron—Haemoglobin—Procarbazine—brain cancer	0.000606	0.00618	CcSEcCtD
Ondansetron—Haemorrhage—Procarbazine—brain cancer	0.000603	0.00614	CcSEcCtD
Ondansetron—SLC47A1—medulla oblongata—brain cancer	0.000593	0.00657	CbGeAlD
Ondansetron—Hepatic failure—Temozolomide—brain cancer	0.000586	0.00597	CcSEcCtD
Ondansetron—HTR1A—brainstem—brain cancer	0.000586	0.00649	CbGeAlD
Ondansetron—Flushing—Procarbazine—brain cancer	0.00056	0.0057	CcSEcCtD
Ondansetron—CYP2D6—hindbrain—brain cancer	0.000555	0.00615	CbGeAlD
Ondansetron—Dysuria—Hydroxyurea—brain cancer	0.000545	0.00555	CcSEcCtD
Ondansetron—Chills—Procarbazine—brain cancer	0.000541	0.00551	CcSEcCtD
Ondansetron—Arrhythmia—Procarbazine—brain cancer	0.000539	0.00549	CcSEcCtD
Ondansetron—Body temperature increased—Lomustine—brain cancer	0.000533	0.00544	CcSEcCtD
Ondansetron—SLC47A1—spinal cord—brain cancer	0.000529	0.00585	CbGeAlD
Ondansetron—HTR1A—telencephalon—brain cancer	0.00052	0.00576	CbGeAlD
Ondansetron—Drowsiness—Hydroxyurea—brain cancer	0.00052	0.0053	CcSEcCtD
Ondansetron—OPRM1—midbrain—brain cancer	0.000506	0.0056	CbGeAlD
Ondansetron—Liver function test abnormal—Carmustine—brain cancer	0.000504	0.00513	CcSEcCtD
Ondansetron—Hypokalaemia—Carmustine—brain cancer	0.000496	0.00506	CcSEcCtD
Ondansetron—OPRM1—spinal cord—brain cancer	0.000493	0.00546	CbGeAlD
Ondansetron—Tremor—Procarbazine—brain cancer	0.000492	0.00501	CcSEcCtD
Ondansetron—Hepatobiliary disease—Hydroxyurea—brain cancer	0.000492	0.00501	CcSEcCtD
Ondansetron—Hypokalaemia—Temozolomide—brain cancer	0.00048	0.00489	CcSEcCtD
Ondansetron—HTR3A—head—brain cancer	0.000478	0.0053	CbGeAlD
Ondansetron—Swelling—Etoposide—brain cancer	0.000478	0.00487	CcSEcCtD
Ondansetron—SLC47A1—endocrine gland—brain cancer	0.000476	0.00527	CbGeAlD
Ondansetron—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.000475	0.00484	CcSEcCtD
Ondansetron—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.000475	0.00484	CcSEcCtD
Ondansetron—Syncope—Procarbazine—brain cancer	0.000471	0.0048	CcSEcCtD
Ondansetron—SLC47A1—head—brain cancer	0.00047	0.0052	CbGeAlD
Ondansetron—Haemoglobin—Hydroxyurea—brain cancer	0.000469	0.00478	CcSEcCtD
Ondansetron—Haemorrhage—Hydroxyurea—brain cancer	0.000467	0.00475	CcSEcCtD
Ondansetron—KCNH2—telencephalon—brain cancer	0.000463	0.00513	CbGeAlD
Ondansetron—HTR1B—midbrain—brain cancer	0.000463	0.00512	CbGeAlD
Ondansetron—Loss of consciousness—Procarbazine—brain cancer	0.000461	0.0047	CcSEcCtD
Ondansetron—Cough—Procarbazine—brain cancer	0.000458	0.00467	CcSEcCtD
Ondansetron—Convulsion—Procarbazine—brain cancer	0.000455	0.00463	CcSEcCtD
Ondansetron—HTR1B—spinal cord—brain cancer	0.000451	0.005	CbGeAlD
Ondansetron—Anxiety—Procarbazine—brain cancer	0.000445	0.00454	CcSEcCtD
Ondansetron—OPRM1—endocrine gland—brain cancer	0.000444	0.00492	CbGeAlD
Ondansetron—OPRM1—head—brain cancer	0.000439	0.00486	CbGeAlD
Ondansetron—Dry mouth—Procarbazine—brain cancer	0.000437	0.00445	CcSEcCtD
Ondansetron—HTR3A—central nervous system—brain cancer	0.000437	0.00483	CbGeAlD
Ondansetron—Anaphylactoid reaction—Etoposide—brain cancer	0.000436	0.00444	CcSEcCtD
Ondansetron—Vomiting—Lomustine—brain cancer	0.000429	0.00437	CcSEcCtD
Ondansetron—SLC47A1—central nervous system—brain cancer	0.000429	0.00475	CbGeAlD
Ondansetron—Dysuria—Temozolomide—brain cancer	0.000426	0.00434	CcSEcCtD
Ondansetron—Angiopathy—Hydroxyurea—brain cancer	0.000423	0.00431	CcSEcCtD
Ondansetron—Shock—Procarbazine—brain cancer	0.000422	0.00429	CcSEcCtD
Ondansetron—SLC47A1—cerebellum—brain cancer	0.000419	0.00464	CbGeAlD
Ondansetron—Chills—Hydroxyurea—brain cancer	0.000419	0.00427	CcSEcCtD
Ondansetron—Tachycardia—Procarbazine—brain cancer	0.000418	0.00426	CcSEcCtD
Ondansetron—Urinary tract infection—Carmustine—brain cancer	0.000409	0.00416	CcSEcCtD
Ondansetron—HTR1B—endocrine gland—brain cancer	0.000406	0.0045	CbGeAlD
Ondansetron—Erythema—Hydroxyurea—brain cancer	0.000406	0.00414	CcSEcCtD
Ondansetron—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000403	0.0041	CcSEcCtD
Ondansetron—HTR1B—head—brain cancer	0.000401	0.00444	CbGeAlD
Ondansetron—Hypotension—Procarbazine—brain cancer	0.0004	0.00408	CcSEcCtD
Ondansetron—OPRM1—central nervous system—brain cancer	0.0004	0.00443	CbGeAlD
Ondansetron—Urinary tract infection—Temozolomide—brain cancer	0.000395	0.00402	CcSEcCtD
Ondansetron—Paraesthesia—Procarbazine—brain cancer	0.000385	0.00392	CcSEcCtD
Ondansetron—Hepatobiliary disease—Temozolomide—brain cancer	0.000384	0.00391	CcSEcCtD
Ondansetron—Somnolence—Procarbazine—brain cancer	0.000381	0.00388	CcSEcCtD
Ondansetron—Toxic epidermal necrolysis—Etoposide—brain cancer	0.00038	0.00387	CcSEcCtD
Ondansetron—Haemoglobin—Carmustine—brain cancer	0.000379	0.00386	CcSEcCtD
Ondansetron—Haemorrhage—Carmustine—brain cancer	0.000377	0.00384	CcSEcCtD
Ondansetron—Ill-defined disorder—Hydroxyurea—brain cancer	0.000377	0.00384	CcSEcCtD
Ondansetron—KCNH2—pituitary gland—brain cancer	0.000377	0.00417	CbGeAlD
Ondansetron—HTR1A—midbrain—brain cancer	0.000373	0.00414	CbGeAlD
Ondansetron—Fatigue—Procarbazine—brain cancer	0.000369	0.00376	CcSEcCtD
Ondansetron—Haemoglobin—Temozolomide—brain cancer	0.000366	0.00373	CcSEcCtD
Ondansetron—Malaise—Hydroxyurea—brain cancer	0.000366	0.00373	CcSEcCtD
Ondansetron—Pain—Procarbazine—brain cancer	0.000366	0.00373	CcSEcCtD
Ondansetron—Constipation—Procarbazine—brain cancer	0.000366	0.00373	CcSEcCtD
Ondansetron—HTR1B—central nervous system—brain cancer	0.000366	0.00406	CbGeAlD
Ondansetron—Haemorrhage—Temozolomide—brain cancer	0.000365	0.00371	CcSEcCtD
Ondansetron—HTR1A—spinal cord—brain cancer	0.000364	0.00403	CbGeAlD
Ondansetron—KCNH2—medulla oblongata—brain cancer	0.000364	0.00403	CbGeAlD
Ondansetron—Visual impairment—Carmustine—brain cancer	0.000364	0.0037	CcSEcCtD
Ondansetron—Bronchospasm—Etoposide—brain cancer	0.000359	0.00365	CcSEcCtD
Ondansetron—CYP2E1—telencephalon—brain cancer	0.000357	0.00395	CbGeAlD
Ondansetron—Feeling abnormal—Procarbazine—brain cancer	0.000353	0.0036	CcSEcCtD
Ondansetron—Eye disorder—Carmustine—brain cancer	0.000353	0.00359	CcSEcCtD
Ondansetron—Convulsion—Hydroxyurea—brain cancer	0.000352	0.00359	CcSEcCtD
Ondansetron—Visual impairment—Temozolomide—brain cancer	0.000351	0.00358	CcSEcCtD
Ondansetron—Gastrointestinal pain—Procarbazine—brain cancer	0.00035	0.00357	CcSEcCtD
Ondansetron—Flushing—Carmustine—brain cancer	0.00035	0.00357	CcSEcCtD
Ondansetron—HTR3A—brain—brain cancer	0.000347	0.00384	CbGeAlD
Ondansetron—Erythema multiforme—Temozolomide—brain cancer	0.000345	0.00351	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000344	0.0035	CcSEcCtD
Ondansetron—Discomfort—Hydroxyurea—brain cancer	0.000342	0.00348	CcSEcCtD
Ondansetron—Eye disorder—Temozolomide—brain cancer	0.000341	0.00347	CcSEcCtD
Ondansetron—SLC47A1—brain—brain cancer	0.00034	0.00377	CbGeAlD
Ondansetron—Urticaria—Procarbazine—brain cancer	0.00034	0.00347	CcSEcCtD
Ondansetron—Abdominal pain—Procarbazine—brain cancer	0.000339	0.00345	CcSEcCtD
Ondansetron—Body temperature increased—Procarbazine—brain cancer	0.000339	0.00345	CcSEcCtD
Ondansetron—Cardiac disorder—Temozolomide—brain cancer	0.000338	0.00345	CcSEcCtD
Ondansetron—Flushing—Temozolomide—brain cancer	0.000338	0.00345	CcSEcCtD
Ondansetron—Arrhythmia—Carmustine—brain cancer	0.000337	0.00343	CcSEcCtD
Ondansetron—KCNH2—midbrain—brain cancer	0.000332	0.00368	CbGeAlD
Ondansetron—Angiopathy—Temozolomide—brain cancer	0.000331	0.00337	CcSEcCtD
Ondansetron—Immune system disorder—Temozolomide—brain cancer	0.000329	0.00336	CcSEcCtD
Ondansetron—Mediastinal disorder—Temozolomide—brain cancer	0.000329	0.00335	CcSEcCtD
Ondansetron—Erythema—Carmustine—brain cancer	0.000328	0.00335	CcSEcCtD
Ondansetron—HTR1A—endocrine gland—brain cancer	0.000328	0.00363	CbGeAlD
Ondansetron—Chills—Temozolomide—brain cancer	0.000327	0.00333	CcSEcCtD
Ondansetron—Nervous system disorder—Hydroxyurea—brain cancer	0.000325	0.00331	CcSEcCtD
Ondansetron—KCNH2—spinal cord—brain cancer	0.000324	0.00359	CbGeAlD
Ondansetron—HTR1A—head—brain cancer	0.000324	0.00359	CbGeAlD
Ondansetron—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000322	0.00328	CcSEcCtD
Ondansetron—Skin disorder—Hydroxyurea—brain cancer	0.000322	0.00328	CcSEcCtD
Ondansetron—Acute coronary syndrome—Etoposide—brain cancer	0.00032	0.00326	CcSEcCtD
Ondansetron—Myocardial infarction—Etoposide—brain cancer	0.000319	0.00325	CcSEcCtD
Ondansetron—CYP2D6—brainstem—brain cancer	0.000318	0.00352	CbGeAlD
Ondansetron—OPRM1—brain—brain cancer	0.000318	0.00352	CbGeAlD
Ondansetron—Erythema—Temozolomide—brain cancer	0.000317	0.00323	CcSEcCtD
Ondansetron—Hypersensitivity—Procarbazine—brain cancer	0.000316	0.00322	CcSEcCtD
Ondansetron—Vision blurred—Carmustine—brain cancer	0.00031	0.00315	CcSEcCtD
Ondansetron—Tremor—Carmustine—brain cancer	0.000308	0.00314	CcSEcCtD
Ondansetron—Asthenia—Procarbazine—brain cancer	0.000307	0.00313	CcSEcCtD
Ondansetron—Hepatobiliary disease—Etoposide—brain cancer	0.000307	0.00313	CcSEcCtD
Ondansetron—Pruritus—Procarbazine—brain cancer	0.000303	0.00309	CcSEcCtD
Ondansetron—Agitation—Carmustine—brain cancer	0.000302	0.00308	CcSEcCtD
Ondansetron—Vision blurred—Temozolomide—brain cancer	0.000299	0.00305	CcSEcCtD
Ondansetron—Tremor—Temozolomide—brain cancer	0.000297	0.00303	CcSEcCtD
Ondansetron—Dyspnoea—Hydroxyurea—brain cancer	0.000296	0.00301	CcSEcCtD
Ondansetron—HTR1A—central nervous system—brain cancer	0.000296	0.00327	CbGeAlD
Ondansetron—Somnolence—Hydroxyurea—brain cancer	0.000295	0.003	CcSEcCtD
Ondansetron—Ill-defined disorder—Temozolomide—brain cancer	0.000294	0.003	CcSEcCtD
Ondansetron—Diarrhoea—Procarbazine—brain cancer	0.000293	0.00299	CcSEcCtD
Ondansetron—KCNH2—endocrine gland—brain cancer	0.000292	0.00323	CbGeAlD
Ondansetron—Agitation—Temozolomide—brain cancer	0.000292	0.00297	CcSEcCtD
Ondansetron—HTR1B—brain—brain cancer	0.000291	0.00322	CbGeAlD
Ondansetron—Angioedema—Temozolomide—brain cancer	0.00029	0.00295	CcSEcCtD
Ondansetron—HTR1A—cerebellum—brain cancer	0.000289	0.0032	CbGeAlD
Ondansetron—KCNH2—head—brain cancer	0.000288	0.00319	CbGeAlD
Ondansetron—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000286	0.00292	CcSEcCtD
Ondansetron—Malaise—Temozolomide—brain cancer	0.000286	0.00292	CcSEcCtD
Ondansetron—Fatigue—Hydroxyurea—brain cancer	0.000286	0.00291	CcSEcCtD
Ondansetron—Convulsion—Carmustine—brain cancer	0.000285	0.0029	CcSEcCtD
Ondansetron—Constipation—Hydroxyurea—brain cancer	0.000284	0.00289	CcSEcCtD
Ondansetron—Pain—Hydroxyurea—brain cancer	0.000284	0.00289	CcSEcCtD
Ondansetron—Dizziness—Procarbazine—brain cancer	0.000283	0.00289	CcSEcCtD
Ondansetron—CYP2D6—telencephalon—brain cancer	0.000282	0.00313	CbGeAlD
Ondansetron—Palpitations—Temozolomide—brain cancer	0.00028	0.00286	CcSEcCtD
Ondansetron—CYP2E1—medulla oblongata—brain cancer	0.00028	0.0031	CbGeAlD
Ondansetron—Chest pain—Carmustine—brain cancer	0.00028	0.00285	CcSEcCtD
Ondansetron—Anxiety—Carmustine—brain cancer	0.000279	0.00284	CcSEcCtD
Ondansetron—Cough—Temozolomide—brain cancer	0.000277	0.00282	CcSEcCtD
Ondansetron—Erythema multiforme—Etoposide—brain cancer	0.000276	0.00281	CcSEcCtD
Ondansetron—Convulsion—Temozolomide—brain cancer	0.000275	0.0028	CcSEcCtD
Ondansetron—Feeling abnormal—Hydroxyurea—brain cancer	0.000273	0.00278	CcSEcCtD
Ondansetron—Eye disorder—Etoposide—brain cancer	0.000273	0.00278	CcSEcCtD
Ondansetron—Vomiting—Procarbazine—brain cancer	0.000272	0.00278	CcSEcCtD
Ondansetron—Cardiac disorder—Etoposide—brain cancer	0.000271	0.00276	CcSEcCtD
Ondansetron—Flushing—Etoposide—brain cancer	0.000271	0.00276	CcSEcCtD
Ondansetron—Rash—Procarbazine—brain cancer	0.00027	0.00275	CcSEcCtD
Ondansetron—Dermatitis—Procarbazine—brain cancer	0.00027	0.00275	CcSEcCtD
Ondansetron—Anxiety—Temozolomide—brain cancer	0.000269	0.00274	CcSEcCtD
Ondansetron—Headache—Procarbazine—brain cancer	0.000268	0.00273	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000268	0.00273	CcSEcCtD
Ondansetron—Discomfort—Temozolomide—brain cancer	0.000267	0.00272	CcSEcCtD
Ondansetron—Angiopathy—Etoposide—brain cancer	0.000265	0.0027	CcSEcCtD
Ondansetron—Dry mouth—Temozolomide—brain cancer	0.000264	0.00269	CcSEcCtD
Ondansetron—Immune system disorder—Etoposide—brain cancer	0.000264	0.00268	CcSEcCtD
Ondansetron—KCNH2—central nervous system—brain cancer	0.000263	0.00291	CbGeAlD
Ondansetron—Mediastinal disorder—Etoposide—brain cancer	0.000263	0.00268	CcSEcCtD
Ondansetron—Body temperature increased—Hydroxyurea—brain cancer	0.000262	0.00267	CcSEcCtD
Ondansetron—Chills—Etoposide—brain cancer	0.000262	0.00267	CcSEcCtD
Ondansetron—Tachycardia—Carmustine—brain cancer	0.000262	0.00267	CcSEcCtD
Ondansetron—Anaphylactic shock—Temozolomide—brain cancer	0.000259	0.00264	CcSEcCtD
Ondansetron—KCNH2—cerebellum—brain cancer	0.000257	0.00285	CbGeAlD
Ondansetron—Nervous system disorder—Temozolomide—brain cancer	0.000254	0.00259	CcSEcCtD
Ondansetron—Skin disorder—Temozolomide—brain cancer	0.000252	0.00256	CcSEcCtD
Ondansetron—Hypotension—Carmustine—brain cancer	0.00025	0.00255	CcSEcCtD
Ondansetron—CYP1A2—endocrine gland—brain cancer	0.00025	0.00277	CbGeAlD
Ondansetron—CYP2E1—spinal cord—brain cancer	0.00025	0.00277	CbGeAlD
Ondansetron—Hypersensitivity—Hydroxyurea—brain cancer	0.000244	0.00249	CcSEcCtD
Ondansetron—CYP3A5—endocrine gland—brain cancer	0.000241	0.00267	CbGeAlD
Ondansetron—Paraesthesia—Carmustine—brain cancer	0.000241	0.00245	CcSEcCtD
Ondansetron—Dyspnoea—Carmustine—brain cancer	0.000239	0.00243	CcSEcCtD
Ondansetron—Somnolence—Carmustine—brain cancer	0.000238	0.00243	CcSEcCtD
Ondansetron—Asthenia—Hydroxyurea—brain cancer	0.000238	0.00242	CcSEcCtD
Ondansetron—CYP2C9—endocrine gland—brain cancer	0.000237	0.00263	CbGeAlD
Ondansetron—Ill-defined disorder—Etoposide—brain cancer	0.000236	0.0024	CcSEcCtD
Ondansetron—HTR1A—brain—brain cancer	0.000235	0.0026	CbGeAlD
Ondansetron—Paraesthesia—Temozolomide—brain cancer	0.000233	0.00237	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Carmustine—brain cancer	0.000231	0.00236	CcSEcCtD
Ondansetron—Dyspnoea—Temozolomide—brain cancer	0.000231	0.00235	CcSEcCtD
Ondansetron—Somnolence—Temozolomide—brain cancer	0.00023	0.00235	CcSEcCtD
Ondansetron—Pain—Carmustine—brain cancer	0.000229	0.00234	CcSEcCtD
Ondansetron—Constipation—Carmustine—brain cancer	0.000229	0.00234	CcSEcCtD
Ondansetron—Malaise—Etoposide—brain cancer	0.000229	0.00233	CcSEcCtD
Ondansetron—Diarrhoea—Hydroxyurea—brain cancer	0.000227	0.00231	CcSEcCtD
Ondansetron—CYP2E1—endocrine gland—brain cancer	0.000225	0.00249	CbGeAlD
Ondansetron—Gastrointestinal disorder—Temozolomide—brain cancer	0.000224	0.00228	CcSEcCtD
Ondansetron—Fatigue—Temozolomide—brain cancer	0.000223	0.00228	CcSEcCtD
Ondansetron—Loss of consciousness—Etoposide—brain cancer	0.000223	0.00227	CcSEcCtD
Ondansetron—CYP2E1—head—brain cancer	0.000222	0.00246	CbGeAlD
Ondansetron—Cough—Etoposide—brain cancer	0.000222	0.00226	CcSEcCtD
Ondansetron—Pain—Temozolomide—brain cancer	0.000222	0.00226	CcSEcCtD
Ondansetron—Constipation—Temozolomide—brain cancer	0.000222	0.00226	CcSEcCtD
Ondansetron—Feeling abnormal—Carmustine—brain cancer	0.000221	0.00225	CcSEcCtD
Ondansetron—Convulsion—Etoposide—brain cancer	0.00022	0.00224	CcSEcCtD
Ondansetron—Dizziness—Hydroxyurea—brain cancer	0.000219	0.00223	CcSEcCtD
Ondansetron—Gastrointestinal pain—Carmustine—brain cancer	0.000219	0.00223	CcSEcCtD
Ondansetron—Chest pain—Etoposide—brain cancer	0.000216	0.0022	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000215	0.00219	CcSEcCtD
Ondansetron—Discomfort—Etoposide—brain cancer	0.000214	0.00218	CcSEcCtD
Ondansetron—Feeling abnormal—Temozolomide—brain cancer	0.000213	0.00217	CcSEcCtD
Ondansetron—Body temperature increased—Carmustine—brain cancer	0.000212	0.00216	CcSEcCtD
Ondansetron—Abdominal pain—Carmustine—brain cancer	0.000212	0.00216	CcSEcCtD
Ondansetron—Gastrointestinal pain—Temozolomide—brain cancer	0.000212	0.00216	CcSEcCtD
Ondansetron—Vomiting—Hydroxyurea—brain cancer	0.000211	0.00215	CcSEcCtD
Ondansetron—Rash—Hydroxyurea—brain cancer	0.000209	0.00213	CcSEcCtD
Ondansetron—KCNH2—brain—brain cancer	0.000209	0.00231	CbGeAlD
Ondansetron—Dermatitis—Hydroxyurea—brain cancer	0.000209	0.00213	CcSEcCtD
Ondansetron—Headache—Hydroxyurea—brain cancer	0.000208	0.00212	CcSEcCtD
Ondansetron—Anaphylactic shock—Etoposide—brain cancer	0.000207	0.00211	CcSEcCtD
Ondansetron—Urticaria—Temozolomide—brain cancer	0.000206	0.0021	CcSEcCtD
Ondansetron—Abdominal pain—Temozolomide—brain cancer	0.000205	0.00209	CcSEcCtD
Ondansetron—Body temperature increased—Temozolomide—brain cancer	0.000205	0.00209	CcSEcCtD
Ondansetron—CYP2E1—central nervous system—brain cancer	0.000203	0.00224	CbGeAlD
Ondansetron—Tachycardia—Etoposide—brain cancer	0.000202	0.00206	CcSEcCtD
Ondansetron—Skin disorder—Etoposide—brain cancer	0.000201	0.00205	CcSEcCtD
Ondansetron—CYP2E1—cerebellum—brain cancer	0.000198	0.00219	CbGeAlD
Ondansetron—Hypersensitivity—Carmustine—brain cancer	0.000197	0.00201	CcSEcCtD
Ondansetron—Hypotension—Etoposide—brain cancer	0.000194	0.00197	CcSEcCtD
Ondansetron—Asthenia—Carmustine—brain cancer	0.000192	0.00196	CcSEcCtD
Ondansetron—Hypersensitivity—Temozolomide—brain cancer	0.000191	0.00194	CcSEcCtD
Ondansetron—Paraesthesia—Etoposide—brain cancer	0.000186	0.0019	CcSEcCtD
Ondansetron—Asthenia—Temozolomide—brain cancer	0.000186	0.00189	CcSEcCtD
Ondansetron—Dyspnoea—Etoposide—brain cancer	0.000185	0.00188	CcSEcCtD
Ondansetron—Somnolence—Etoposide—brain cancer	0.000184	0.00188	CcSEcCtD
Ondansetron—Diarrhoea—Carmustine—brain cancer	0.000183	0.00187	CcSEcCtD
Ondansetron—Pruritus—Temozolomide—brain cancer	0.000183	0.00187	CcSEcCtD
Ondansetron—CYP3A4—endocrine gland—brain cancer	0.000181	0.002	CbGeAlD
Ondansetron—Gastrointestinal disorder—Etoposide—brain cancer	0.000179	0.00182	CcSEcCtD
Ondansetron—Fatigue—Etoposide—brain cancer	0.000179	0.00182	CcSEcCtD
Ondansetron—CYP2D6—endocrine gland—brain cancer	0.000178	0.00197	CbGeAlD
Ondansetron—Dizziness—Carmustine—brain cancer	0.000177	0.00181	CcSEcCtD
Ondansetron—Pain—Etoposide—brain cancer	0.000177	0.00181	CcSEcCtD
Ondansetron—Constipation—Etoposide—brain cancer	0.000177	0.00181	CcSEcCtD
Ondansetron—Diarrhoea—Temozolomide—brain cancer	0.000177	0.00181	CcSEcCtD
Ondansetron—CYP2D6—head—brain cancer	0.000176	0.00195	CbGeAlD
Ondansetron—Dizziness—Temozolomide—brain cancer	0.000171	0.00175	CcSEcCtD
Ondansetron—Feeling abnormal—Etoposide—brain cancer	0.000171	0.00174	CcSEcCtD
Ondansetron—Vomiting—Carmustine—brain cancer	0.00017	0.00174	CcSEcCtD
Ondansetron—Gastrointestinal pain—Etoposide—brain cancer	0.000169	0.00173	CcSEcCtD
Ondansetron—Rash—Carmustine—brain cancer	0.000169	0.00172	CcSEcCtD
Ondansetron—Dermatitis—Carmustine—brain cancer	0.000169	0.00172	CcSEcCtD
Ondansetron—Headache—Carmustine—brain cancer	0.000168	0.00171	CcSEcCtD
Ondansetron—Vomiting—Temozolomide—brain cancer	0.000165	0.00168	CcSEcCtD
Ondansetron—Urticaria—Etoposide—brain cancer	0.000165	0.00168	CcSEcCtD
Ondansetron—Body temperature increased—Etoposide—brain cancer	0.000164	0.00167	CcSEcCtD
Ondansetron—Abdominal pain—Etoposide—brain cancer	0.000164	0.00167	CcSEcCtD
Ondansetron—Rash—Temozolomide—brain cancer	0.000163	0.00166	CcSEcCtD
Ondansetron—Dermatitis—Temozolomide—brain cancer	0.000163	0.00166	CcSEcCtD
Ondansetron—CYP3A4—central nervous system—brain cancer	0.000163	0.00181	CbGeAlD
Ondansetron—Headache—Temozolomide—brain cancer	0.000162	0.00165	CcSEcCtD
Ondansetron—CYP2E1—brain—brain cancer	0.000161	0.00178	CbGeAlD
Ondansetron—CYP2D6—central nervous system—brain cancer	0.00016	0.00178	CbGeAlD
Ondansetron—CYP2D6—cerebellum—brain cancer	0.000157	0.00174	CbGeAlD
Ondansetron—Hypersensitivity—Etoposide—brain cancer	0.000153	0.00156	CcSEcCtD
Ondansetron—Asthenia—Etoposide—brain cancer	0.000149	0.00152	CcSEcCtD
Ondansetron—Pruritus—Etoposide—brain cancer	0.000147	0.00149	CcSEcCtD
Ondansetron—Diarrhoea—Etoposide—brain cancer	0.000142	0.00144	CcSEcCtD
Ondansetron—Dizziness—Etoposide—brain cancer	0.000137	0.0014	CcSEcCtD
Ondansetron—Vomiting—Etoposide—brain cancer	0.000132	0.00134	CcSEcCtD
Ondansetron—Rash—Etoposide—brain cancer	0.000131	0.00133	CcSEcCtD
Ondansetron—Dermatitis—Etoposide—brain cancer	0.000131	0.00133	CcSEcCtD
Ondansetron—Headache—Etoposide—brain cancer	0.00013	0.00132	CcSEcCtD
Ondansetron—CYP2D6—brain—brain cancer	0.000127	0.00141	CbGeAlD
Ondansetron—HTR4—Signaling by GPCR—SMO—brain cancer	5.84e-05	0.00218	CbGpPWpGaD
Ondansetron—OPRM1—TCR Signaling Pathway—RELA—brain cancer	5.65e-05	0.00211	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—ABR—brain cancer	5.55e-05	0.00207	CbGpPWpGaD
Ondansetron—HTR3A—SIDS Susceptibility Pathways—VEGFA—brain cancer	5.53e-05	0.00206	CbGpPWpGaD
Ondansetron—HTR1A—SIDS Susceptibility Pathways—HES1—brain cancer	5.45e-05	0.00203	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—GLI2—brain cancer	5.36e-05	0.002	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—GLI1—brain cancer	5.04e-05	0.00188	CbGpPWpGaD
Ondansetron—HTR1B—GPCR ligand binding—SHH—brain cancer	5.02e-05	0.00187	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—PTCH2—brain cancer	5e-05	0.00187	CbGpPWpGaD
Ondansetron—HTR4—GPCR downstream signaling—VAV1—brain cancer	4.91e-05	0.00183	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—SUFU—brain cancer	4.78e-05	0.00178	CbGpPWpGaD
Ondansetron—HTR1B—GPCR ligand binding—PTCH1—brain cancer	4.76e-05	0.00178	CbGpPWpGaD
Ondansetron—HTR1B—GPCR ligand binding—SMO—brain cancer	4.76e-05	0.00178	CbGpPWpGaD
Ondansetron—CYP3A4—Biological oxidations—CYP2C9—brain cancer	4.7e-05	0.00175	CbGpPWpGaD
Ondansetron—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	4.63e-05	0.00173	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—GFAP—brain cancer	4.61e-05	0.00172	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—OR4C12—brain cancer	4.58e-05	0.00171	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—OR14C36—brain cancer	4.58e-05	0.00171	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—VAV1—brain cancer	4.45e-05	0.00166	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—SHH—brain cancer	4.43e-05	0.00165	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—PTCH2—brain cancer	4.41e-05	0.00165	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—HEY1—brain cancer	4.37e-05	0.00163	CbGpPWpGaD
Ondansetron—KCNH2—SIDS Susceptibility Pathways—CTNNB1—brain cancer	4.35e-05	0.00163	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—ABR—brain cancer	4.32e-05	0.00161	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—DLL1—brain cancer	4.28e-05	0.0016	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—SMO—brain cancer	4.2e-05	0.00157	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—PTCH1—brain cancer	4.2e-05	0.00157	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—OR4C12—brain cancer	4.05e-05	0.00151	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—OR14C36—brain cancer	4.05e-05	0.00151	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—ABR—brain cancer	3.92e-05	0.00146	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—DTX2—brain cancer	3.9e-05	0.00145	CbGpPWpGaD
Ondansetron—KCNH2—SIDS Susceptibility Pathways—VEGFA—brain cancer	3.83e-05	0.00143	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—SHH—brain cancer	3.82e-05	0.00143	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—ABR—brain cancer	3.81e-05	0.00142	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—PTCH2—brain cancer	3.81e-05	0.00142	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—SHH—brain cancer	3.64e-05	0.00136	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—SMO—brain cancer	3.62e-05	0.00135	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—PTCH1—brain cancer	3.62e-05	0.00135	CbGpPWpGaD
Ondansetron—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	3.62e-05	0.00135	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—TRPC6—brain cancer	3.51e-05	0.00131	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—OR4C12—brain cancer	3.49e-05	0.0013	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—OR14C36—brain cancer	3.49e-05	0.0013	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—ABR—brain cancer	3.46e-05	0.00129	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—SMO—brain cancer	3.45e-05	0.00129	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—PTCH1—brain cancer	3.45e-05	0.00129	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—DTX2—brain cancer	3.44e-05	0.00128	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—ABR—brain cancer	3.29e-05	0.00123	CbGpPWpGaD
Ondansetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	3.26e-05	0.00122	CbGpPWpGaD
Ondansetron—HTR4—GPCR downstream signaling—PIK3CG—brain cancer	3.11e-05	0.00116	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—ABR—brain cancer	2.99e-05	0.00112	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—DTX2—brain cancer	2.97e-05	0.00111	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—PTCH2—brain cancer	2.95e-05	0.0011	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—HES5—brain cancer	2.86e-05	0.00107	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—PIK3CG—brain cancer	2.83e-05	0.00106	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—STRADA—brain cancer	2.78e-05	0.00104	CbGpPWpGaD
Ondansetron—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	2.77e-05	0.00103	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—NOTCH2—brain cancer	2.76e-05	0.00103	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—TRPC6—brain cancer	2.74e-05	0.00102	CbGpPWpGaD
Ondansetron—HTR1A—SIDS Susceptibility Pathways—CTNNB1—brain cancer	2.73e-05	0.00102	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—VAV1—brain cancer	2.63e-05	0.000982	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PTCH2—brain cancer	2.61e-05	0.000973	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—SHH—brain cancer	2.58e-05	0.000961	CbGpPWpGaD
Ondansetron—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	2.55e-05	0.000952	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—HES5—brain cancer	2.52e-05	0.000942	CbGpPWpGaD
Ondansetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	2.49e-05	0.000931	CbGpPWpGaD
Ondansetron—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	2.49e-05	0.000931	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—TRPC6—brain cancer	2.48e-05	0.000927	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—STRADA—brain cancer	2.45e-05	0.000915	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—SMO—brain cancer	2.44e-05	0.000911	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—PTCH1—brain cancer	2.44e-05	0.000911	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—TRPC6—brain cancer	2.41e-05	0.000901	CbGpPWpGaD
Ondansetron—HTR1A—SIDS Susceptibility Pathways—VEGFA—brain cancer	2.4e-05	0.000897	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—CYP2C9—brain cancer	2.39e-05	0.000892	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.34e-05	0.000872	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—ABR—brain cancer	2.32e-05	0.000865	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—SHH—brain cancer	2.27e-05	0.000848	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—HES1—brain cancer	2.26e-05	0.000845	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PTCH2—brain cancer	2.25e-05	0.00084	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—GLI2—brain cancer	2.24e-05	0.000836	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—TRPC6—brain cancer	2.19e-05	0.000818	CbGpPWpGaD
Ondansetron—HTR4—GPCR downstream signaling—IL2—brain cancer	2.19e-05	0.000818	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—HES5—brain cancer	2.18e-05	0.000813	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—PTCH1—brain cancer	2.16e-05	0.000804	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—SMO—brain cancer	2.16e-05	0.000804	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—PDGFRA—brain cancer	2.15e-05	0.000804	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—STRADA—brain cancer	2.12e-05	0.00079	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—GLI1—brain cancer	2.1e-05	0.000786	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—SPP1—brain cancer	2.09e-05	0.000781	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—TRPC6—brain cancer	2.08e-05	0.000778	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—VAV1—brain cancer	2.05e-05	0.000765	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—ABR—brain cancer	2.05e-05	0.000763	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—BSG—brain cancer	2.03e-05	0.000758	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2e-05	0.000746	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—SUFU—brain cancer	2e-05	0.000745	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—IL2—brain cancer	1.99e-05	0.000743	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—GLI2—brain cancer	1.98e-05	0.000737	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—SHH—brain cancer	1.96e-05	0.000732	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—GFAP—brain cancer	1.93e-05	0.000718	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—TRPC6—brain cancer	1.89e-05	0.000706	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—IRS2—brain cancer	1.89e-05	0.000706	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—VAV1—brain cancer	1.86e-05	0.000695	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—SMO—brain cancer	1.86e-05	0.000694	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—PTCH1—brain cancer	1.86e-05	0.000694	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—GLI1—brain cancer	1.86e-05	0.000693	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—HEY1—brain cancer	1.82e-05	0.000681	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—VAV1—brain cancer	1.81e-05	0.000675	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—DLL1—brain cancer	1.79e-05	0.000668	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—ABR—brain cancer	1.77e-05	0.000659	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—SUFU—brain cancer	1.76e-05	0.000657	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—IDH1—brain cancer	1.75e-05	0.000652	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—CYP2C9—brain cancer	1.73e-05	0.000646	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—CYP2C9—brain cancer	1.73e-05	0.000645	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.71e-05	0.000638	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—GLI2—brain cancer	1.71e-05	0.000636	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—GFAP—brain cancer	1.7e-05	0.000634	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—APC—brain cancer	1.67e-05	0.000624	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—PIK3CG—brain cancer	1.67e-05	0.000624	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—VAV1—brain cancer	1.64e-05	0.000613	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—HEY1—brain cancer	1.61e-05	0.000601	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—GLI1—brain cancer	1.6e-05	0.000598	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—DLL1—brain cancer	1.58e-05	0.000589	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—VAV1—brain cancer	1.56e-05	0.000583	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—EGFR—brain cancer	1.52e-05	0.000568	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—SHH—brain cancer	1.52e-05	0.000568	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—SUFU—brain cancer	1.52e-05	0.000567	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—BSG—brain cancer	1.47e-05	0.000549	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—BSG—brain cancer	1.47e-05	0.000548	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—TRPC6—brain cancer	1.47e-05	0.000548	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—GFAP—brain cancer	1.47e-05	0.000547	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—SMO—brain cancer	1.44e-05	0.000538	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—PTCH1—brain cancer	1.44e-05	0.000538	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—VAV1—brain cancer	1.42e-05	0.000529	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—HEY1—brain cancer	1.39e-05	0.000519	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—ENO2—brain cancer	1.38e-05	0.000516	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—DLL1—brain cancer	1.36e-05	0.000509	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—SHH—brain cancer	1.34e-05	0.000501	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—RELA—brain cancer	1.31e-05	0.000487	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—PIK3CG—brain cancer	1.3e-05	0.000486	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—ERBB2—brain cancer	1.3e-05	0.000484	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—TRPC6—brain cancer	1.29e-05	0.000483	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—SMO—brain cancer	1.27e-05	0.000475	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PTCH1—brain cancer	1.27e-05	0.000475	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—IDH1—brain cancer	1.27e-05	0.000472	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—IDH1—brain cancer	1.26e-05	0.000471	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CYP2C9—brain cancer	1.23e-05	0.000458	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—PIK3CG—brain cancer	1.18e-05	0.000441	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—IL2—brain cancer	1.18e-05	0.000439	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—SHH—brain cancer	1.16e-05	0.000433	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—NOTCH2—brain cancer	1.15e-05	0.00043	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—PIK3CG—brain cancer	1.15e-05	0.000429	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—CCND1—brain cancer	1.15e-05	0.000428	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—CTNNB1—brain cancer	1.14e-05	0.000424	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—TRPC6—brain cancer	1.12e-05	0.000417	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—VAV1—brain cancer	1.1e-05	0.00041	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—SMO—brain cancer	1.1e-05	0.00041	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PTCH1—brain cancer	1.1e-05	0.00041	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—BSG—brain cancer	1.04e-05	0.00039	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—PIK3CG—brain cancer	1.04e-05	0.000389	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CYP2C9—brain cancer	1.04e-05	0.000388	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—BSG—brain cancer	1.04e-05	0.000386	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—NOTCH2—brain cancer	1.02e-05	0.00038	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—ENO2—brain cancer	1e-05	0.000373	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—VEGFA—brain cancer	9.99e-06	0.000373	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—ENO2—brain cancer	9.98e-06	0.000373	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—PIK3CG—brain cancer	9.91e-06	0.00037	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—STAT3—brain cancer	9.89e-06	0.000369	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—VAV1—brain cancer	9.7e-06	0.000362	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—HES1—brain cancer	9.46e-06	0.000353	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—MYC—brain cancer	9.19e-06	0.000343	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—IL2—brain cancer	9.16e-06	0.000342	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—PDGFRA—brain cancer	9e-06	0.000336	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—PIK3CG—brain cancer	9e-06	0.000336	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—EGFR—brain cancer	8.99e-06	0.000336	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—IDH1—brain cancer	8.98e-06	0.000335	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—IDH1—brain cancer	8.9e-06	0.000332	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—BSG—brain cancer	8.85e-06	0.00033	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—NOTCH2—brain cancer	8.79e-06	0.000328	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—SPP1—brain cancer	8.74e-06	0.000326	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—VAV1—brain cancer	8.37e-06	0.000313	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—HES1—brain cancer	8.34e-06	0.000311	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—IL2—brain cancer	8.32e-06	0.00031	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—IL2—brain cancer	8.08e-06	0.000302	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CYP2C9—brain cancer	8.03e-06	0.0003	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PDGFRA—brain cancer	7.95e-06	0.000297	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IRS2—brain cancer	7.9e-06	0.000295	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—SPP1—brain cancer	7.71e-06	0.000288	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—IDH1—brain cancer	7.61e-06	0.000284	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—TP53—brain cancer	7.55e-06	0.000282	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—IL2—brain cancer	7.34e-06	0.000274	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.25e-06	0.000271	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—HES1—brain cancer	7.2e-06	0.000269	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—ENO2—brain cancer	7.1e-06	0.000265	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—ENO2—brain cancer	7.04e-06	0.000263	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—PIK3CG—brain cancer	6.98e-06	0.000261	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—APC—brain cancer	6.98e-06	0.000261	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—IL2—brain cancer	6.98e-06	0.00026	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IRS2—brain cancer	6.98e-06	0.00026	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PDGFRA—brain cancer	6.86e-06	0.000256	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—BSG—brain cancer	6.83e-06	0.000255	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—SPP1—brain cancer	6.66e-06	0.000248	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—EGFR—brain cancer	6.36e-06	0.000237	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—PIK3CG—brain cancer	6.34e-06	0.000237	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—IL2—brain cancer	6.33e-06	0.000236	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.2e-06	0.000231	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PIK3CG—brain cancer	6.16e-06	0.00023	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—APC—brain cancer	6.16e-06	0.00023	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IRS2—brain cancer	6.02e-06	0.000225	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ENO2—brain cancer	6.01e-06	0.000224	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—IDH1—brain cancer	5.87e-06	0.000219	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—EGFR—brain cancer	5.61e-06	0.000209	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—RELA—brain cancer	5.45e-06	0.000204	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—ERBB2—brain cancer	5.42e-06	0.000202	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—APC—brain cancer	5.32e-06	0.000198	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PIK3CG—brain cancer	5.32e-06	0.000198	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IL2—brain cancer	4.91e-06	0.000183	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—EGFR—brain cancer	4.84e-06	0.000181	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—RELA—brain cancer	4.81e-06	0.00018	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CCND1—brain cancer	4.79e-06	0.000179	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—ERBB2—brain cancer	4.78e-06	0.000179	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CTNNB1—brain cancer	4.74e-06	0.000177	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ENO2—brain cancer	4.64e-06	0.000173	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PIK3CG—brain cancer	4.59e-06	0.000171	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PIK3CG—brain cancer	4.58e-06	0.000171	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IL2—brain cancer	4.34e-06	0.000162	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CCND1—brain cancer	4.23e-06	0.000158	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CTNNB1—brain cancer	4.19e-06	0.000156	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—VEGFA—brain cancer	4.17e-06	0.000156	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—RELA—brain cancer	4.16e-06	0.000155	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—STAT3—brain cancer	4.13e-06	0.000154	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—ERBB2—brain cancer	4.13e-06	0.000154	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—MYC—brain cancer	3.84e-06	0.000143	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—EGFR—brain cancer	3.76e-06	0.00014	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IL2—brain cancer	3.74e-06	0.00014	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—VEGFA—brain cancer	3.68e-06	0.000138	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—STAT3—brain cancer	3.65e-06	0.000136	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CCND1—brain cancer	3.65e-06	0.000136	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CTNNB1—brain cancer	3.61e-06	0.000135	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—MYC—brain cancer	3.39e-06	0.000127	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—EGFR—brain cancer	3.32e-06	0.000124	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PIK3CG—brain cancer	3.26e-06	0.000122	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PIK3CG—brain cancer	3.23e-06	0.000121	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—VEGFA—brain cancer	3.18e-06	0.000119	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—TP53—brain cancer	3.15e-06	0.000118	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—STAT3—brain cancer	3.15e-06	0.000118	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—MYC—brain cancer	2.93e-06	0.000109	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—EGFR—brain cancer	2.86e-06	0.000107	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—TP53—brain cancer	2.78e-06	0.000104	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PIK3CG—brain cancer	2.76e-06	0.000103	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—TP53—brain cancer	2.4e-06	8.97e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PIK3CG—brain cancer	2.13e-06	7.95e-05	CbGpPWpGaD
